Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $359.5000 (2.58%) ($359.2300 - $369.3100) on Tue. Sep. 2, 2014. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.83% (three month average) | | RSI | 70 | | Latest Price | $359.5000(2.58%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | | Weekly Trend | REGN advances 1% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
XBI(38%) XLV(38%) QQQ(31%) SPY(30%) XLK(28%) | | Factors Impacting REGN price | REGN will decline at least -0.915% in a week (0% probabilities).
VIXM(-13%) TLT(-6%) SHY(-3%) IGOV(-3%) UUP(-2%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.915% (StdDev 1.83%) | | Hourly BBV | 0 () | | Intraday Trend | -2% | | | | | |
|
| 5 Day Moving Average | $352.19(2.08%) | | 10 Day Moving Average | $348.55(3.14%) | | 20 Day Moving Average | $345.31(4.11%) | | To recent high | 0% | | To recent low | 29.6% | | Market Cap | $38.117b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |